Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition

21 Jun 2023

Abstract excerpt

IgA nephropathy (IgAN) is the most common glomerular disease worldwide, with an estimated annual incidence of 25 per million adults. Despite optimized supportive care, some patients fail to achieve disease control and suffer progressive deterioration of kidney function. In this subpopulation of patients, the Kidney Disease: Improving Global Outcomes 2021 guidelines recommend consideration of corticosteroids;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Platelet Disorders and Treatments
Share to Renal Diseases and Glomerulopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37705895
DOI: 10.1016/j.ekir.2023.06.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges in IgA Nephropathy Management: An Era of Complement InhibitionPMID 37705895Read ↗

Targeting complement in IgA nephropathySemantic proximity Read ↗

The complement system in IgAN: mechanistic context for therapeutic opportunitiesSemantic proximity Read ↗

IgA nephropathy: new insights into the role of complementSemantic proximity Read ↗

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudySemantic proximity Read ↗

Targeted Complement Treatments in Glomerulopathies: A Comprehensive ReviewSemantic proximity Read ↗

Kidney diseasesSemantic proximity Read ↗

IgA Nephropathy.Semantic proximity Read ↗

Omics are Getting Us Closer to Understanding IgA NephropathySemantic proximity Read ↗

The role of complement in kidney diseaseSemantic proximity Read ↗

IgA nephropathy.Semantic proximity Read ↗

C3 Glomerulopathy: A Current Perspective in an Evolving LandscapeSemantic proximity Read ↗

The Pathophysiology of IgA NephropathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.